# Neonatal Phase 1 Valacyclovir Study

> **NCT05468619** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 17 (actual)

## Conditions studied

- Herpes Simplex

## Interventions

- **DRUG:** Valacyclovir

## Key facts

- **NCT ID:** NCT05468619
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-08-07
- **Primary completion:** 2025-06-08
- **Final completion:** 2025-07-15
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2026-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05468619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05468619, "Neonatal Phase 1 Valacyclovir Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05468619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*